Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives.

Matteo Cotta RamusinoGiulia PeriniDaniele AltomarePaola BarbarinoWendy WeidnerGabriella Salvini PorroFrederik BarkhofGil D RabinoviciWiesje M van der FlierGiovanni B FrisoniValentina GaribottoStefan TeipelMarina Boccardi

Published in: European journal of nuclear medicine and molecular imaging (2021)

Current studies validating amyloid-PET already assessed outcomes for clinical utility, although non-clinician-based outcomes were inconsistent. A wider participation of stakeholders may help produce a more thorough and systematic definition and assessment of outcomes of clinical utility and help collect evidence informing decisions on reimbursement of amyloid-PET.

Keyphrases

computed tomography
pet ct
positron emission tomography
type diabetes
metabolic syndrome
adipose tissue
hiv infected
skeletal muscle